TiGenix : announcement FY 2011 results

(Thomson Reuters ONE) -


Regulated information
March 8, 2012


TiGenix to announce 2011 results on March 15


Leuven (BELGIUM) - March 8, 2012 - TiGenix (NYSE Euronext: TIG) announced
today the Company will issue its full-year 2011 results at 7:00 CET on March
15, followed by a discussion of the results and a business update in a
conference call at 15:00 CET.

Title:                     TiGenix Full-Year 2011 Financial Results
Date:                    March 15, 2012
Time:                    15:00 CET (14:00 GMT/9:00 EST)

To participate, please listen to the webcast or call one of the following
telephone numbers.

International dial-in numbers:

                        +32 2 620 0138                      Belgium
                        +34 91 791 7146                    Spain
                        +31 20 721 9158                    Netherlands
                        +44 20 3106 4822                  UK
                        +1 646 254 3388                    USA

For more information:
Hans Herklots
Director Investor & Media Relations
hans.herklots(at)tigenix.com
+32 16 39 79 73


About TiGenix

TiGenix NV (NYSE Euronext Brussels: TIG) is a leading European cell therapy
company with two marketed products for cartilage repair, and a strong pipeline
with clinical stage allogeneic adult stem cell programs for the treatment
of autoimmune and inflammatory diseases. TiGenix is based out of Leuven

(Belgium) and has operations in Madrid (Spain), Cambridge (UK) and Sittard-
Geleen (the Netherlands). For more information please visit www.tigenix.com.






This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: TiGenix via Thomson Reuters ONE

[HUG#1592386]

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 08.03.2012 - 09:31 Uhr
Sprache: Deutsch
News-ID 123033
Anzahl Zeichen: 2550

contact information:
Town:

Leuven

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 170 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"TiGenix : announcement FY 2011 results"
steht unter der journalistisch-redaktionellen Verantwortung von

TiGenix (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

TiGenix Business Update & Financial Highlights for the First Half of 2013 ...

LEUVEN, BELGIUM -- (Marketwired) -- 08/20/13 -- (NYSE Euronext: TIG)(NYSE Euronext: TIG),ChondroCelect:ChondroCelect sales EUR 2.3 million, up 55% from H1 2012ChondroCelect obtains national reimbursement in SpainProduct development pipelineADMIRE-CD ...

TiGenix Provides ChondroCelect Update ...

LEUVEN, BELGIUM -- (Marketwired) -- 06/07/13 -- TiGenix (NYSE Euronext: TIG), the European leader in cell therapy, today provided an update on the commercial prospects of ChondroCelect, its characterized chondrocyte implantation for symptomatic cart ...

TiGenix Business Update & Financial Highlights for Q1 of 2013 ...

LEUVEN, BELGIUM -- (Marketwired) -- 05/14/13 -- (EURONEXT BRUSSELS: TIG)(EURONEXT BRUSSELS: TIG)ChondroCelect:TiGenix obtained reimbursement in Spain for ChondroCelectChondroCelect sales benefit from continued uptake in Belgium and in the Netherlan ...

Alle Meldungen von TiGenix